SANDS CAPITAL MANAGEMENT, LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1020066 ARLINGTON, VA

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$105,457,907

+$38,113,441 QoQ

Shares Held

3,158,368

-1.7% QoQ

Ownership

3.20%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

of 310 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 65% Shared 0% None 35%

Healthcare · as of Jun 30, 2026

SANDS CAPITAL MANAGEMENT, LLC holds $382,489,101 across 2 Biotechnology names. RARE ranks #2 (27.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	ARGX	Argenx SE	298,599	$277,031,194
2	RARE	Ultragenyx Pharmaceutical Inc. This page	3,158,368	$105,457,907

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$105,457,907	3,158,368	-1.7%	Shares	Sole	2026-08-13
2026-03-31	$67,344,466	3,214,533	-7.8%	Shares	Sole	2026-05-08
2025-12-31	$80,171,652	3,485,724	-7.5%	Shares	Sole	2026-02-13
2025-09-30	$113,397,178	3,769,853	-4.4%	Shares	Sole	2025-11-13
2025-06-30	$143,385,114	3,943,485	-5.3%	Shares	Sole	2025-08-13
2025-03-31	$150,762,543	4,163,561	-3.1%	Shares	Sole	2025-05-14
2024-12-31	$180,816,986	4,298,003	-16.0%	Shares	Sole	2025-02-13
2024-12-31	$180,816,986	4,298,003	—	Shares	Sole	2025-02-12
2024-09-30	$284,319,065	5,118,255	-4.4%	Shares	Sole	2024-11-13
2024-06-30	$220,080,225	5,354,750	+38.7%	Shares	Sole	2024-08-13
2024-03-31	$180,197,580	3,859,447	-6.3%	Shares	Sole	2024-05-14
2023-12-31	$196,923,142	4,118,008	+59.8%	Shares	Sole	2024-02-13
2023-09-30	$91,877,786	2,577,217	-3.6%	Shares	Sole	2023-11-14
2023-06-30	$123,334,920	2,673,638	—	Shares	Sole	2023-08-15
No filing history on record for this holder in this stock.